Cargando…
Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial
Up to 30 May 2021, the cumulative number of patients diagnosed with corona virus disease-19 (COVID-19) globally has exceeded 170 million, with more than 152 million patients recovered from COVID-19. However, the long-term effect of the virus infection on the human body’s function is unknown for conv...
Autores principales: | Chen, Yuqin, He, Wenjun, Lu, Wenju, Xing, Yue, Bai, Jianling, Yu, Hao, Zhou, Jiawei, Liang, Jingyi, Chen, Jiyuan, Hou, Chi, Zhong, Bihua, Wang, Ting, Feng, Huazhuo, Chen, Xu, Wang, Tao, Yang, Kai, Zhang, Nuofu, Zhong, Nanshan, Liu, Chunli, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351033/ https://www.ncbi.nlm.nih.gov/pubmed/34394913 http://dx.doi.org/10.1177/20458940211032125 |
Ejemplares similares
-
Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial
por: Chen, Yuqin, et al.
Publicado: (2022) -
Bufei Huoxue Capsule Attenuates PM2.5-Induced Pulmonary Inflammation in Mice
por: Jing, Yue, et al.
Publicado: (2017) -
Systematic Pharmacology-Based Strategy to Explore the Mechanism of Bufei Huoxue Capsule in the Treatment of Chronic Obstructive Pulmonary Disease
por: Shi, Liangtian, et al.
Publicado: (2022) -
Gene Network Mechanism of Zhilong Huoxue Tongyu Capsule in Treating Cerebral Ischemia–Reperfusion
por: Li, Na, et al.
Publicado: (2022) -
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
por: Wang, Tao, et al.
Publicado: (2020)